The Latest
-
How Moderna executives are cashing in on COVID-19 vaccine stock speculation
-
ASX 200 up 0.55%: Cochlear jumps on FDA approval, Adbri crushed on contract loss
-
Tubi share price soars 250% with COVID-19 business update
-
Why Lovisa, PointsBet, Transurban, & WiseTech shares are racing higher